USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Mar 31, 2022 (est) | Dec 31, 2021 | - | $-0.07 | $-0.12 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Mar 31, 2022 (est) | Dec 31, 2021 | - | $0.00 | $0.00 |
Greenwich Lifesciences's next estimated earnings date (based on same quarter last year's date) is Mar 31, 2022 for the fiscal quarter ending Dec 31, 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 1 | $-0.59 | $-0.59 | $-0.59 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-0.59 | $-0.59 | $-0.59 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 1 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $-0.06 | $-0.07 | -16.67% |
| Aug 13, 2021 | Jun 2021 | $-0.32 | $-0.06 | 81.25% |
| May 20, 2021 | Mar 2021 | $-0.32 | $-0.05 | 84.38% |
| Mar 31, 2021 | Dec 2020 | $-0.93 | $-0.12 | 87.10% |
| Nov 16, 2020 | Sep 2020 | - | $-0.02 | - |
| Sep 30, 2020 | Jun 2020 | - | $-0.03 | - |
| Jun 30, 2020 | Mar 2020 | - | $-0.02 | - |
| Mar 31, 2020 | Dec 2019 | - | $-0.03 | - |
| Sep 30, 2019 | Jun 2019 | - | $-1.15 | - |
| Jun 30, 2019 | Mar 2019 | - | $-12.83 | - |
| Mar 31, 2019 | Dec 2018 | - | $-0.73 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $-1.02 | $-0.20 | - |
| Mar 31, 2020 | Dec 2019 | - | $-14.01 | - |
| Mar 31, 2019 | Dec 2018 | - | $-0.73 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Aug 13, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 20, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 31, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 16, 2020 | Sep 2020 | - | $0.00 | - |
| Sep 30, 2020 | Jun 2020 | - | $0.00 | - |
| Jun 30, 2020 | Mar 2020 | - | $0.00 | - |
| Mar 31, 2020 | Dec 2019 | - | $0.00 | - |
| Sep 30, 2019 | Jun 2019 | - | - | - |
| Jun 30, 2019 | Mar 2019 | - | - | - |
| Mar 31, 2019 | Dec 2018 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 31, 2020 | Dec 2019 | - | $0.00 | - |
| Mar 31, 2019 | Dec 2018 | - | $0.00 | - |
GLSI's next estimated earnings date (based on same quarter last year's report date) is Mar 31, 2022 for the fiscal quarter ending Dec 31, 2021.
Greenwich Lifesciences's previous earnings date was Nov 15, 2021 for its fiscal quarter ended Sep 30, 2021.
GLSI's earnings per share (EPS) was $-0.07, missing the consensus analysts forecast of $-0.06 by -16.67%.
The EPS was lower than the previous fiscal quarter (Jun 2021) by 16.67%, and lower than the same period a year before (Sep 2020) by 225.58%.
Revenues were $0.00.
The company reported a net income of $-863.12K.Free cash flow for the quarter was $-894.64K , compared to $-604.32K last quarter and $0.00 a year before.
Greenwich Lifesciences's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.
GLSI's earnings per share (EPS) was $-0.20, beating the consensus analysts forecast of $-1.02 by -80.86% , and higher than the previous year's EPS (Dec 2019) by -98.61%.
Revenues were $0.00.
The company reported a net income of $-1.86M.
Greenwich Lifesciences reported a free cash flow of $-1.15M for its fiscal year, compared to $-293.27K a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
